Connecticut 2021 Regular Session

Connecticut Senate Bill SB00115

Introduced
1/12/21  
Refer
1/12/21  
Refer
1/12/21  
Refer
3/10/21  
Report Pass
3/26/21  
Report Pass
3/26/21  
Refer
4/9/21  
Refer
4/9/21  
Report Pass
4/15/21  
Report Pass
4/15/21  
Refer
5/12/21  

Caption

An Act Prohibiting The Sale Of Cigarettes, Tobacco Products, Electronic Nicotine Delivery Systems And Vapor Products By Health Care Facilities, Pharmacies And Places Of Business With A Pharmacy Located Therein.

Impact

If enacted, SB00115 will significantly alter state laws surrounding tobacco and nicotine product sales, particularly in health care settings. This includes voiding any existing licenses for the sale of these products in health facilities and pharmacies, which is seen as a move to prioritize health over profit. The bill underscores a commitment to public health measures aimed at reducing tobacco use and preventing its sale in convenience locations where individuals seek health services or medications, further aligning health care providers with anti-smoking initiatives.

Summary

SB00115 is a legislative proposal aimed at prohibiting the sale of cigarettes, tobacco products, electronic nicotine delivery systems, and vapor products by health care facilities, pharmacies, and places of business that have a pharmacy. This bill seeks to enhance public health by restricting access to nicotine products in environments typically associated with health and well-being, potentially reducing smoking rates, especially among younger demographics who may frequent these establishments. The bill's provisions are set to take effect on January 1, 2022, thereby phasing out any existing licenses for such sales in the mentioned venues.

Sentiment

The sentiment regarding SB00115 appears to be largely positive among public health advocates who argue that reducing the availability of tobacco products in health-conscious settings will potentially lessen smoking rates and promote healthier lifestyle choices. However, there may also be apprehension from businesses that typically profit from tobacco sales; they may view the bill as limiting their operations and revenue streams. The nuanced debate reflects a broader conflict between public health objectives and economic interests.

Contention

While SB00115 draws support for its public health intentions, potential points of contention may arise from business groups that argue this could unfairly affect their operations without providing ample time to adapt. Additionally, there are concerns regarding enforcement of the new regulations and how this will impact businesses currently selling tobacco and related products. The bill’s implications could spark discussions on broader tobacco control policies and their effectiveness in achieving lower smoking rates across the state.

Companion Bills

No companion bills found.

Similar Bills

CA AB852

Health care practitioners: electronic prescriptions.

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA SB1379

Pharmacy: remote services.

CA AB1557

Pharmacy: electronic prescriptions.

MD SB371

State Board of Pharmacy - Renewal Notices - Electronic Means

MD HB565

State Board of Pharmacy - Renewal Notices - Electronic Means

AR HB1620

To Amend The Law Concerning Pharmacy Benefits Managers; And To Regulate Processing And Payment Of Pharmacy Claims.

LA HB548

Requires that the prescribers transmit prescriptions for opioids to pharmacies electronically (EG SEE FISC NOTE SG EX See Note)